Skip to content
OpenCapital
Get started

Veracyte VCYT Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$136K-85.8%
Guardant Health logo
Guardant HealthGH
——

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0×0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's accretion (amortization) of discounts and premiums, investments?
Veracyte (VCYT) reported accretion (amortization) of discounts and premiums, investments of $614K in Q1 2026.
How has Veracyte's accretion (amortization) of discounts and premiums, investments changed year-over-year?
Veracyte's accretion (amortization) of discounts and premiums, investments decreased by 30.4% year-over-year, from $882K to $614K.
What does accretion (amortization) of discounts and premiums, investments mean?
Represents the non-cash adjustment to the carrying value of investment securities to reflect the amortization of premiums or accretion of discounts over the life of the instrument. This ensures that interest income is recognized on an effective interest basis rather than a cash basis.